25 XP   0   0   10

Vericel Corp Ord
Buy, Hold or Sell?

Let's analyse Vericel Corp Ord together

PenkeI guess you are interested in Vericel Corp Ord. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Vericel Corp Ord. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Vericel Corp Ord

I send you an email if I find something interesting about Vericel Corp Ord.

Quick analysis of Vericel Corp Ord (30 sec.)










What can you expect buying and holding a share of Vericel Corp Ord? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$4.47
Expected worth in 1 year
$5.04
How sure are you?
60.0%

+ What do you gain per year?

Total Gains per Share
$0.57
Return On Investment
1.2%

For what price can you sell your share?

Current Price per Share
$46.26
Expected price per share
$41.58 - $53.05
How sure are you?
50%

1. Valuation of Vericel Corp Ord (5 min.)




Live pricePrice per Share (EOD)

$46.26

Intrinsic Value Per Share

$-8.39 - $4.63

Total Value Per Share

$-3.92 - $9.11

2. Growth of Vericel Corp Ord (5 min.)




Is Vericel Corp Ord growing?

Current yearPrevious yearGrowGrow %
How rich?$225.9m$179.3m$26.4m12.9%

How much money is Vericel Corp Ord making?

Current yearPrevious yearGrowGrow %
Making money-$506k-$4.1m$3.5m710.7%
Net Profit Margin-3.6%-12.2%--

How much money comes from the company's main activities?

3. Financial Health of Vericel Corp Ord (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#228 / 1019

Most Revenue
#157 / 1019

Most Profit
#206 / 1019

Most Efficient
#462 / 1019

What can you expect buying and holding a share of Vericel Corp Ord? (5 min.)

Welcome investor! Vericel Corp Ord's management wants to use your money to grow the business. In return you get a share of Vericel Corp Ord.

What can you expect buying and holding a share of Vericel Corp Ord?

First you should know what it really means to hold a share of Vericel Corp Ord. And how you can make/lose money.

Speculation

The Price per Share of Vericel Corp Ord is $46.26. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Vericel Corp Ord.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Vericel Corp Ord, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $4.47. Based on the TTM, the Book Value Change Per Share is $0.14 per quarter. Based on the YOY, the Book Value Change Per Share is $0.12 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Vericel Corp Ord.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.260.6%-0.020.0%-0.09-0.2%-0.04-0.1%-0.06-0.1%
Usd Book Value Change Per Share0.250.5%0.140.3%0.120.3%0.120.3%0.110.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.250.5%0.140.3%0.120.3%0.120.3%0.110.2%
Usd Price Per Share35.61-34.01-28.24-29.32-17.40-
Price to Earnings Ratio34.61--53.50--21.78--32.35--18.35-
Price-to-Total Gains Ratio143.12-273.97-314.90-203.49-43.47-
Price to Book Ratio7.96-8.09-7.69-9.42-11.94-
Price-to-Total Gains Ratio143.12-273.97-314.90-203.49-43.47-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share46.26
Number of shares21
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.140.12
Usd Total Gains Per Share0.140.12
Gains per Quarter (21 shares)2.972.48
Gains per Year (21 shares)11.889.91
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
101220100
20241402010
30362603020
40483804030
50595005040
60716205950
70837406960
80958607970
901079808980
10011911009990

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.03.00.025.0%3.09.00.025.0%7.013.00.035.0%9.031.00.022.5%9.0101.00.08.2%
Book Value Change Per Share4.00.00.0100.0%12.00.00.0100.0%17.03.00.085.0%24.016.00.060.0%46.064.00.041.8%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.0110.00.0%
Total Gains per Share4.00.00.0100.0%12.00.00.0100.0%17.03.00.085.0%24.016.00.060.0%46.064.00.041.8%

Fundamentals of Vericel Corp Ord

About Vericel Corp Ord

Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in North America. The company markets autologous cell therapy products comprising MACI, an autologous cultured chondrocytes on porcine collagen membrane for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns; and NexoBrid, a biological orphan product for eschar removal in adults with deep partial-thickness and/or full-thickness thermal burns. The company was formerly known as Aastrom Biosciences, Inc. Vericel Corporation was incorporated in 1989 and is headquartered in Cambridge, Massachusetts.

Fundamental data was last updated by Penke on 2024-04-11 02:35:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Vericel Corp Ord.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Vericel Corp Ord earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Vericel Corp Ord to the Biotechnology industry mean.
  • A Net Profit Margin of 20.0% means that $0.20 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Vericel Corp Ord:

  • The MRQ is 20.0%. The company is making a huge profit. +2
  • The TTM is -3.6%. The company is making a loss. -1
Trends
Current periodCompared to+/- 
MRQ20.0%TTM-3.6%+23.6%
TTM-3.6%YOY-12.2%+8.6%
TTM-3.6%5Y-8.1%+4.4%
5Y-8.1%10Y-1,894.5%+1,886.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ20.0%-197.2%+217.2%
TTM-3.6%-210.4%+206.8%
YOY-12.2%-279.3%+267.1%
5Y-8.1%-436.8%+428.7%
10Y-1,894.5%-599.3%-1,295.2%
1.1.2. Return on Assets

Shows how efficient Vericel Corp Ord is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Vericel Corp Ord to the Biotechnology industry mean.
  • 3.7% Return on Assets means that Vericel Corp Ord generated $0.04 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Vericel Corp Ord:

  • The MRQ is 3.7%. Using its assets, the company is less efficient in making profit.
  • The TTM is -0.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ3.7%TTM-0.4%+4.0%
TTM-0.4%YOY-1.7%+1.4%
TTM-0.4%5Y-1.1%+0.7%
5Y-1.1%10Y-7.1%+6.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.7%-13.6%+17.3%
TTM-0.4%-12.9%+12.5%
YOY-1.7%-11.9%+10.2%
5Y-1.1%-14.2%+13.1%
10Y-7.1%-16.2%+9.1%
1.1.3. Return on Equity

Shows how efficient Vericel Corp Ord is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Vericel Corp Ord to the Biotechnology industry mean.
  • 5.8% Return on Equity means Vericel Corp Ord generated $0.06 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Vericel Corp Ord:

  • The MRQ is 5.8%. Using its investors money, the company is less efficient in making profit.
  • The TTM is -0.5%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ5.8%TTM-0.5%+6.2%
TTM-0.5%YOY-2.4%+2.0%
TTM-0.5%5Y-1.5%+1.0%
5Y-1.5%10Y-17.8%+16.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ5.8%-17.0%+22.8%
TTM-0.5%-16.1%+15.6%
YOY-2.4%-15.4%+13.0%
5Y-1.5%-20.0%+18.5%
10Y-17.8%-21.1%+3.3%

1.2. Operating Efficiency of Vericel Corp Ord.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Vericel Corp Ord is operating .

  • Measures how much profit Vericel Corp Ord makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Vericel Corp Ord to the Biotechnology industry mean.
  • An Operating Margin of 19.6% means the company generated $0.20  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Vericel Corp Ord:

  • The MRQ is 19.6%. The company is operating efficient. +1
  • The TTM is -5.4%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ19.6%TTM-5.4%+25.0%
TTM-5.4%YOY-12.7%+7.3%
TTM-5.4%5Y-8.6%+3.2%
5Y-8.6%10Y-1,473.1%+1,464.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ19.6%-286.1%+305.7%
TTM-5.4%-224.4%+219.0%
YOY-12.7%-288.4%+275.7%
5Y-8.6%-475.2%+466.6%
10Y-1,473.1%-624.7%-848.4%
1.2.2. Operating Ratio

Measures how efficient Vericel Corp Ord is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.80 means that the operating costs are $0.80 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Vericel Corp Ord:

  • The MRQ is 0.804. The company is less efficient in keeping operating costs low.
  • The TTM is 1.061. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ0.804TTM1.061-0.257
TTM1.061YOY1.127-0.066
TTM1.0615Y1.091-0.030
5Y1.09110Y15.722-14.631
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8042.997-2.193
TTM1.0613.247-2.186
YOY1.1273.766-2.639
5Y1.0915.675-4.584
10Y15.7227.857+7.865

1.3. Liquidity of Vericel Corp Ord.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Vericel Corp Ord is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 4.49 means the company has $4.49 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Vericel Corp Ord:

  • The MRQ is 4.495. The company is very able to pay all its short-term debts. +2
  • The TTM is 5.246. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.495TTM5.246-0.752
TTM5.246YOY6.085-0.838
TTM5.2465Y6.122-0.875
5Y6.12210Y4.754+1.367
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.4953.930+0.565
TTM5.2464.251+0.995
YOY6.0855.436+0.649
5Y6.1226.045+0.077
10Y4.7546.363-1.609
1.3.2. Quick Ratio

Measures if Vericel Corp Ord is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Vericel Corp Ord to the Biotechnology industry mean.
  • A Quick Ratio of 4.94 means the company can pay off $4.94 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Vericel Corp Ord:

  • The MRQ is 4.943. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 5.768. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ4.943TTM5.768-0.824
TTM5.768YOY7.162-1.394
TTM5.7685Y7.357-1.590
5Y7.35710Y5.409+1.948
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.9433.629+1.314
TTM5.7684.065+1.703
YOY7.1625.397+1.765
5Y7.3575.993+1.364
10Y5.4096.277-0.868

1.4. Solvency of Vericel Corp Ord.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Vericel Corp Ord assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Vericel Corp Ord to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.36 means that Vericel Corp Ord assets are financed with 36.1% credit (debt) and the remaining percentage (100% - 36.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Vericel Corp Ord:

  • The MRQ is 0.361. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.337. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.361TTM0.337+0.024
TTM0.337YOY0.287+0.050
TTM0.3375Y0.303+0.034
5Y0.30310Y0.369-0.067
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3610.332+0.029
TTM0.3370.334+0.003
YOY0.2870.268+0.019
5Y0.3030.366-0.063
10Y0.3690.390-0.021
1.4.2. Debt to Equity Ratio

Measures if Vericel Corp Ord is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Vericel Corp Ord to the Biotechnology industry mean.
  • A Debt to Equity ratio of 56.5% means that company has $0.57 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Vericel Corp Ord:

  • The MRQ is 0.565. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.513. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.565TTM0.513+0.053
TTM0.513YOY0.402+0.111
TTM0.5135Y0.437+0.076
5Y0.43710Y0.777-0.340
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5650.381+0.184
TTM0.5130.390+0.123
YOY0.4020.334+0.068
5Y0.4370.434+0.003
10Y0.7770.466+0.311

2. Market Valuation of Vericel Corp Ord

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Vericel Corp Ord generates.

  • Above 15 is considered overpriced but always compare Vericel Corp Ord to the Biotechnology industry mean.
  • A PE ratio of 34.61 means the investor is paying $34.61 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Vericel Corp Ord:

  • The EOD is 44.960. Based on the earnings, the company is overpriced. -1
  • The MRQ is 34.610. Based on the earnings, the company is overpriced. -1
  • The TTM is -53.500. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD44.960MRQ34.610+10.351
MRQ34.610TTM-53.500+88.109
TTM-53.500YOY-21.781-31.719
TTM-53.5005Y-32.350-21.150
5Y-32.35010Y-18.355-13.995
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD44.960-2.315+47.275
MRQ34.610-2.560+37.170
TTM-53.500-2.664-50.836
YOY-21.781-4.122-17.659
5Y-32.350-6.258-26.092
10Y-18.355-6.108-12.247
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Vericel Corp Ord:

  • The EOD is 259.516. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is 199.770. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 153.610. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD259.516MRQ199.770+59.746
MRQ199.770TTM153.610+46.160
TTM153.610YOY404.057-250.447
TTM153.6105Y27.865+125.746
5Y27.86510Y44.242-16.377
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD259.516-3.067+262.583
MRQ199.770-3.251+203.021
TTM153.610-3.545+157.155
YOY404.057-5.595+409.652
5Y27.865-8.315+36.180
10Y44.242-8.708+52.950
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Vericel Corp Ord is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 7.96 means the investor is paying $7.96 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Vericel Corp Ord:

  • The EOD is 10.342. Based on the equity, the company is expensive. -2
  • The MRQ is 7.961. Based on the equity, the company is overpriced. -1
  • The TTM is 8.086. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD10.342MRQ7.961+2.381
MRQ7.961TTM8.086-0.126
TTM8.086YOY7.685+0.401
TTM8.0865Y9.424-1.338
5Y9.42410Y11.938-2.514
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD10.3421.905+8.437
MRQ7.9612.111+5.850
TTM8.0862.095+5.991
YOY7.6852.836+4.849
5Y9.4243.443+5.981
10Y11.9383.794+8.144
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Vericel Corp Ord.

3.1. Institutions holding Vericel Corp Ord

Institutions are holding 110.743% of the shares of Vericel Corp Ord.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31BlackRock Inc16.40550.007279370634596696.1474
2023-12-31Brown Capital Management, LLC14.09443.64356818933-60621-0.8812
2023-12-31Vanguard Group Inc6.97410.00263374093485141.4588
2023-12-31RTW INVESTMENTS, LLC6.64071.78713212794-79079-2.4022
2023-12-31State Street Corporation5.50820.00462664883-28780-1.0684
2023-12-31Conestoga Capital Advisors, LLC4.83661.250423399601092154.8959
2023-12-31GW&K Investment Management, LLC2.73520.43941323306-46128-3.3684
2023-12-31Morgan Stanley - Brokerage Accounts2.68260.00411297846-58580-4.3187
2023-12-31Macquarie Group Ltd2.36910.04721146193-27984-2.3833
2023-12-31Loomis, Sayles & Company LP2.35950.06231141526-36134-3.0683
2023-12-31New York State Common Retirement Fund2.1930.05231060965-30717-2.8137
2023-12-31Geode Capital Management, LLC2.12350.00381027379501615.133
2023-12-31Goldman Sachs Group Inc1.9520.00394439046141695.5364
2023-12-31BNP Paribas Investment Partners SA1.90350.0913920898-2317-0.251
2023-12-31William Blair Investment Management, LLC1.72570.0865834885-20322-2.3763
2023-12-31Dimensional Fund Advisors, Inc.1.50980.007673042680801.1186
2023-12-31JPMorgan Chase & Co1.42960.0024691630609449.6631
2023-12-31Ameriprise Financial Inc1.39570.0072675222-38792-5.4329
2023-09-30Point72 Asset Management, L.P.1.27650.060461759811671223.3011
2023-12-31Nuveen Asset Management, LLC1.25440.00760690444990.7468
Total 81.36967.569939366894+889756+2.3%

3.2. Funds holding Vericel Corp Ord

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-09-30Brown Capital Mgmt Small Co Inv7.99783.7895386938100
2024-03-28iShares Core S&P Small-Cap ETF6.66230.20873223240-11607-0.3588
2024-02-29Conestoga Small Cap Investors3.33231.81471612200177501.1132
2024-02-29Vanguard Total Stock Mkt Idx Inv3.09170.00441495786-5710-0.3803
2024-03-28SPDR® S&P Biotech ETF2.96810.98931435995181201.278
2024-03-28iShares Russell 2000 ETF2.41640.0929116908181160.6991
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr1.44930.031470117925810.3695
2023-12-31Conestoga Small Cap Growth1.41651.4981685299211603.1861
2024-02-29Delaware Ivy Small Cap Growth C1.35582.1109655928-87532-11.7736
2024-02-29Loomis Sayles Small Cap Growth Instl1.33141.2833644126-17331-2.6201
2024-01-31Fidelity Small Cap Growth1.30650.473963206820374947.5695
2024-02-29BNP Paribas Health Cr Innovtr Cl Cap1.29551.6527626765199763.2921
2024-01-31Fidelity Small Cap Index0.99650.083648210072391.5244
2024-03-28iShares S&P Small-Cap 600 Growth ETF0.96430.410646651700
2024-02-29JPM Thematics Genetic Thrps C2 Acc USD0.93832.6916453972-6868-1.4903
2024-03-28SPDR® Portfolio S&P 600 Sm Cap ETF0.8730.20894223574350.1031
2024-03-28iShares Russell 2000 Growth ETF0.85370.1844413046-480-0.1161
2024-02-29Congress Small Cap Growth Institutional0.82681.81244000004000000
2024-02-29Vanguard Tax-Managed Small Cap Adm0.77070.191737285700
2024-03-28iShares Biotechnology ETF0.73560.242635589600
Total 41.582519.775620117793+569598+2.8%

3.3. Insider Transactions

Insiders are holding 0.832% of the shares of Vericel Corp Ord.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-03-27Robert L Md ZerbeSELL327851.57
2024-03-13Dominick ColangeloSELL1750044.67
2024-03-11Michael HalpinSELL787444.71
2024-03-08Sean C FlynnSELL811545.33
2024-01-29Robert L Md ZerbeSELL230044.22
2024-01-25Robert L Md ZerbeSELL20044.02
2024-01-22Robert L Md ZerbeSELL800041.85
2024-01-18Dominick ColangeloSELL1672638.58
2024-01-12Robert L Md ZerbeSELL220038.09
2023-07-14Robert L Md ZerbeSELL100038.84
2023-06-22Robert L Md ZerbeSELL300036

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Vericel Corp Ord compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.2490.141+76%0.124+101%0.118+111%0.110+127%
Book Value Per Share--4.4734.205+6%3.690+21%3.108+44%1.885+137%
Current Ratio--4.4955.246-14%6.085-26%6.122-27%4.754-5%
Debt To Asset Ratio--0.3610.337+7%0.287+26%0.303+19%0.369-2%
Debt To Equity Ratio--0.5650.513+10%0.402+41%0.437+29%0.777-27%
Dividend Per Share----0%-0%-0%-0%
Eps--0.257-0.019+107%-0.087+134%-0.036+114%-0.060+123%
Free Cash Flow Per Share--0.0450.040+12%0.052-14%0.045-1%-0.019+143%
Free Cash Flow To Equity Per Share--0.0700.058+21%0.057+24%0.071-1%0.075-6%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--4.632--------
Intrinsic Value_10Y_min---8.390--------
Intrinsic Value_1Y_max--0.295--------
Intrinsic Value_1Y_min---0.208--------
Intrinsic Value_3Y_max--1.014--------
Intrinsic Value_3Y_min---1.177--------
Intrinsic Value_5Y_max--1.890--------
Intrinsic Value_5Y_min---2.743--------
Market Cap2238081930.000+20%1798732320.0001664154581.250+8%1371446165.000+31%1426579349.000+26%845852244.500+113%
Net Profit Margin--0.200-0.036+118%-0.122+161%-0.081+140%-18.945+9577%
Operating Margin--0.196-0.054+128%-0.127+165%-0.086+144%-14.731+7620%
Operating Ratio--0.8041.061-24%1.127-29%1.091-26%15.722-95%
Pb Ratio10.342+23%7.9618.086-2%7.685+4%9.424-16%11.938-33%
Pe Ratio44.960+23%34.610-53.500+255%-21.781+163%-32.350+193%-18.355+153%
Price Per Share46.260+23%35.61034.005+5%28.235+26%29.323+21%17.401+105%
Price To Free Cash Flow Ratio259.516+23%199.770153.610+30%404.057-51%27.865+617%44.242+352%
Price To Total Gains Ratio185.929+23%143.124273.966-48%314.898-55%203.487-30%43.466+229%
Quick Ratio--4.9435.768-14%7.162-31%7.357-33%5.409-9%
Return On Assets--0.037-0.004+110%-0.017+147%-0.011+129%-0.071+293%
Return On Equity--0.058-0.005+108%-0.024+142%-0.015+126%-0.178+409%
Total Gains Per Share--0.2490.141+76%0.124+101%0.118+111%0.110+127%
Usd Book Value--225952000.000205809500.000+10%179352500.000+26%151290350.000+49%91642500.000+147%
Usd Book Value Change Per Share--0.2490.141+76%0.124+101%0.118+111%0.110+127%
Usd Book Value Per Share--4.4734.205+6%3.690+21%3.108+44%1.885+137%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps--0.257-0.019+107%-0.087+134%-0.036+114%-0.060+123%
Usd Free Cash Flow--2251000.0001949500.000+15%2522750.000-11%2208050.000+2%-923525.000+141%
Usd Free Cash Flow Per Share--0.0450.040+12%0.052-14%0.045-1%-0.019+143%
Usd Free Cash Flow To Equity Per Share--0.0700.058+21%0.057+24%0.071-1%0.075-6%
Usd Market Cap2238081930.000+20%1798732320.0001664154581.250+8%1371446165.000+31%1426579349.000+26%845852244.500+113%
Usd Price Per Share46.260+23%35.61034.005+5%28.235+26%29.323+21%17.401+105%
Usd Profit--12993000.000-506000.000+104%-4102000.000+132%-1635200.000+113%-2848825.000+122%
Usd Revenue--64995999.00049378999.750+32%41091250.000+58%38004699.950+71%26230749.975+148%
Usd Total Gains Per Share--0.2490.141+76%0.124+101%0.118+111%0.110+127%
 EOD+4 -4MRQTTM+25 -8YOY+22 -115Y+21 -1210Y+26 -8

4.2. Fundamental Score

Let's check the fundamental score of Vericel Corp Ord based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1544.960
Price to Book Ratio (EOD)Between0-110.342
Net Profit Margin (MRQ)Greater than00.200
Operating Margin (MRQ)Greater than00.196
Quick Ratio (MRQ)Greater than14.943
Current Ratio (MRQ)Greater than14.495
Debt to Asset Ratio (MRQ)Less than10.361
Debt to Equity Ratio (MRQ)Less than10.565
Return on Equity (MRQ)Greater than0.150.058
Return on Assets (MRQ)Greater than0.050.037
Total6/10 (60.0%)

4.3. Technical Score

Let's check the technical score of Vericel Corp Ord based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5040.880
Ma 20Greater thanMa 5049.351
Ma 50Greater thanMa 10047.426
Ma 100Greater thanMa 20042.353
OpenGreater thanClose47.940
Total4/5 (80.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets353,657
Total Liabilities127,705
Total Stockholder Equity225,952
 As reported
Total Liabilities 127,705
Total Stockholder Equity+ 225,952
Total Assets = 353,657

Assets

Total Assets353,657
Total Current Assets205,631
Long-term Assets148,026
Total Current Assets
Cash And Cash Equivalents 86,866
Short-term Investments 40,469
Net Receivables 58,356
Inventory 13,087
Other Current Assets 6,853
Total Current Assets  (as reported)205,631
Total Current Assets  (calculated)205,631
+/-0
Long-term Assets
Property Plant Equipment 115,097
Long Term Investments 25,283
Intangible Assets 6,875
Long-term Assets Other 771
Long-term Assets  (as reported)148,026
Long-term Assets  (calculated)148,026
+/- 0

Liabilities & Shareholders' Equity

Total Current Liabilities45,749
Long-term Liabilities81,956
Total Stockholder Equity225,952
Total Current Liabilities
Short-term Debt 6,187
Accounts payable 22,347
Other Current Liabilities 17,215
Total Current Liabilities  (as reported)45,749
Total Current Liabilities  (calculated)45,749
+/-0
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt81,856
Long-term Liabilities Other 100
Long-term Liabilities  (as reported)81,956
Long-term Liabilities  (calculated)81,956
+/- 0
Total Stockholder Equity
Common Stock629,229
Retained Earnings -403,177
Accumulated Other Comprehensive Income -100
Total Stockholder Equity (as reported)225,952
Total Stockholder Equity (calculated)225,952
+/-0
Other
Capital Stock629,229
Cash and Short Term Investments 127,335
Common Stock Shares Outstanding 50,512
Liabilities and Stockholders Equity 353,657
Net Debt 1,277
Net Invested Capital 225,952
Net Working Capital 159,882
Property Plant and Equipment Gross 137,303
Short Long Term Debt Total 88,143



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-311999-12-311999-09-301999-06-301999-03-311998-12-311998-09-301998-06-301998-03-311997-12-311997-09-301997-06-301997-03-311996-12-311996-09-30
> Total Assets 
8,900
6,100
22,900
18,400
14,874
20,912
16,643
12,374
13,743
11,740
8,938
9,540
6,254
4,433
9,759
13,437
12,506
11,286
9,830
11,905
16,726
14,810
13,675
11,553
10,214
9,098
7,292
12,155
14,958
12,502
12,171
18,166
17,071
24,539
37,005
33,897
31,326
27,976
24,081
44,881
41,153
38,240
34,569
32,848
29,351
35,895
30,962
26,217
22,330
19,600
21,955
19,276
20,166
16,624
24,569
20,531
15,970
32,800
26,231
20,304
14,072
7,739
38,664
30,439
22,708
15,178
10,582
5,683
12,202
9,215
9,878
19,836
50,381
47,579
44,492
41,219
35,818
34,309
33,057
29,434
28,022
48,598
40,588
36,534
40,278
54,577
52,409
122,193
124,463
118,689
141,229
125,826
137,527
153,238
152,890
146,691
157,504
205,608
211,464
221,945
224,143
243,705
240,288
244,815
248,017
273,003
265,096
310,711
318,125
353,657
353,657318,125310,711265,096273,003248,017244,815240,288243,705224,143221,945211,464205,608157,504146,691152,890153,238137,527125,826141,229118,689124,463122,19352,40954,57740,27836,53440,58848,59828,02229,43433,05734,30935,81841,21944,49247,57950,38119,8369,8789,21512,2025,68310,58215,17822,70830,43938,6647,73914,07220,30426,23132,80015,97020,53124,56916,62420,16619,27621,95519,60022,33026,21730,96235,89529,35132,84834,56938,24041,15344,88124,08127,97631,32633,89737,00524,53917,07118,16612,17112,50214,95812,1557,2929,09810,21411,55313,67514,81016,72611,9059,83011,28612,50613,4379,7594,4336,2549,5408,93811,74013,74312,37416,64320,91214,87418,40022,9006,1008,900
   > Total Current Assets 
7,700
4,900
21,800
17,400
13,933
20,078
15,845
11,649
13,061
11,128
8,376
9,038
5,806
4,049
9,420
13,145
12,264
11,073
9,647
11,726
16,561
14,649
13,442
11,347
10,036
8,822
6,970
11,853
14,653
12,211
11,863
17,832
16,685
24,073
36,391
33,144
30,226
26,852
22,980
43,665
39,930
36,963
33,189
30,177
26,745
33,431
28,641
24,063
20,347
17,768
20,289
17,791
18,778
15,384
23,435
19,518
14,988
31,700
25,078
19,045
12,578
6,175
37,197
29,130
21,462
13,990
9,526
4,730
11,361
8,476
9,236
14,112
44,716
41,490
37,919
33,546
28,516
27,343
25,817
22,305
21,099
44,723
36,950
33,041
36,311
50,506
48,202
117,520
119,256
112,783
109,601
94,048
104,718
111,655
119,162
115,762
125,382
123,560
127,213
138,520
144,946
158,462
151,880
155,094
166,375
186,866
177,545
182,871
186,211
205,631
205,631186,211182,871177,545186,866166,375155,094151,880158,462144,946138,520127,213123,560125,382115,762119,162111,655104,71894,048109,601112,783119,256117,52048,20250,50636,31133,04136,95044,72321,09922,30525,81727,34328,51633,54637,91941,49044,71614,1129,2368,47611,3614,7309,52613,99021,46229,13037,1976,17512,57819,04525,07831,70014,98819,51823,43515,38418,77817,79120,28917,76820,34724,06328,64133,43126,74530,17733,18936,96339,93043,66522,98026,85230,22633,14436,39124,07316,68517,83211,86312,21114,65311,8536,9708,82210,03611,34713,44214,64916,56111,7269,64711,07312,26413,1459,4204,0495,8069,0388,37611,12813,06111,64915,84520,07813,93317,40021,8004,9007,700
       Cash And Cash Equivalents 
5,900
4,100
4,700
1,900
1,505
1,270
2,671
2,078
6,121
9,852
6,435
7,528
5,015
3,550
3,805
2,064
3,764
2,926
4,052
10,659
10,660
8,781
10,953
8,605
6,930
6,760
5,064
10,512
13,110
10,784
10,426
16,926
14,995
12,588
13,494
14,408
23,107
18,225
12,838
9,034
11,724
13,979
27,608
13,439
24,300
16,259
26,713
16,492
18,700
16,326
19,076
17,000
17,357
14,739
17,844
14,119
14,466
31,200
24,621
18,521
11,947
5,530
36,733
28,666
21,089
13,638
9,226
4,494
10,816
8,059
8,836
7,263
37,578
30,343
25,903
20,218
18,724
14,581
13,544
9,835
8,880
22,978
19,847
14,041
15,466
26,862
29,777
94,969
53,289
18,286
35,084
13,962
36,905
26,889
45,623
55,704
43,507
33,620
58,154
51,761
54,553
68,330
55,659
56,054
65,216
51,067
61,834
43,023
60,473
86,866
86,86660,47343,02361,83451,06765,21656,05455,65968,33054,55351,76158,15433,62043,50755,70445,62326,88936,90513,96235,08418,28653,28994,96929,77726,86215,46614,04119,84722,9788,8809,83513,54414,58118,72420,21825,90330,34337,5787,2638,8368,05910,8164,4949,22613,63821,08928,66636,7335,53011,94718,52124,62131,20014,46614,11917,84414,73917,35717,00019,07616,32618,70016,49226,71316,25924,30013,43927,60813,97911,7249,03412,83818,22523,10714,40813,49412,58814,99516,92610,42610,78413,11010,5125,0646,7606,9308,60510,9538,78110,66010,6594,0522,9263,7642,0643,8053,5505,0157,5286,4359,8526,1212,0782,6711,2701,5051,9004,7004,1005,900
       Short-term Investments 
0
0
0
0
12,126
18,511
12,763
9,134
6,565
1,000
1,000
0
0
0
5,215
10,681
7,969
6,998
4,509
-1,500
4,508
4,502
1,000
1,000
1,000
0
0
0
0
0
0
0
0
10,000
21,941
18,006
6,055
8,000
9,500
33,963
27,283
22,333
4,999
14,886
14,886
14,930
0
5,970
0
0
0
0
0
0
5,000
5,000
5,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
44,462
64,638
49,001
52,047
37,760
42,829
35,957
25,086
42,035
42,187
25,402
39,214
43,738
35,068
44,888
44,638
45,724
68,471
57,442
54,808
44,870
40,469
40,46944,87054,80857,44268,47145,72444,63844,88835,06843,73839,21425,40242,18742,03525,08635,95742,82937,76052,04749,00164,63844,46200000000000000000000000000000005,0005,0005,0000000005,970014,93014,88614,8864,99922,33327,28333,9639,5008,0006,05518,00621,94110,000000000001,0001,0001,0004,5024,508-1,5004,5096,9987,96910,6815,2150001,0001,0006,5659,13412,76318,51112,1260000
       Net Receivables 
200
100
200
200
209
244
221
167
183
175
157
113
193
140
169
242
193
172
155
129
110
172
145
120
117
195
320
350
373
310
276
246
326
408
259
193
169
123
192
139
104
121
96
78
71
107
63
18
66
70
254
58
519
23
0
16
17
0
18
0
9
9
11
9
9
28
28
0
0
0
0
4,317
3,959
8,191
9,166
8,980
7,639
10,919
9,669
9,031
7,871
17,093
12,127
14,729
15,430
18,270
13,162
17,499
15,528
23,454
18,774
21,084
19,958
32,168
24,171
23,655
26,174
34,504
29,122
31,732
28,910
37,437
31,855
33,664
34,296
46,539
38,359
38,319
39,729
58,356
58,35639,72938,31938,35946,53934,29633,66431,85537,43728,91031,73229,12234,50426,17423,65524,17132,16819,95821,08418,77423,45415,52817,49913,16218,27015,43014,72912,12717,0937,8719,0319,66910,9197,6398,9809,1668,1913,9594,31700002828991199018017160235195825470661863107717896121104139192123169193259408326246276310373350320195117120145172110129155172193242169140193113157175183167221244209200200100200
       Other Current Assets 
1,600
700
16,900
15,300
93
53
190
270
192
101
192
253
528
318
231
158
338
977
931
213
424
348
350
225
504
649
454
185
625
489
483
271
731
716
471
421
874
499
447
528
819
518
478
1,766
2,366
2,135
1,865
1,583
1,581
1,372
959
732
902
622
591
383
505
426
439
524
622
636
453
455
364
324
300
236
545
417
400
610
1,468
1,036
845
2,270
514
464
662
1,046
741
1,164
1,018
1,116
1,366
1,581
1,358
1,327
2,339
2,847
2,679
2,167
3,272
2,953
6,129
2,900
3,586
3,893
4,213
2,854
4,686
4,246
5,093
4,809
4,410
4,803
4,540
5,044
5,430
6,853
6,8535,4305,0444,5404,8034,4104,8095,0934,2464,6862,8544,2133,8933,5862,9006,1292,9533,2722,1672,6792,8472,3391,3271,3581,5811,3661,1161,0181,1647411,0466624645142,2708451,0361,4686104004175452363003243644554536366225244394265053835916229027329591,3721,5811,5831,8652,1352,3661,766478518819528447499874421471716731271483489625185454649504225350348424213931977338158231318528253192101192270190539315,30016,9007001,600
   > Long-term Assets 
1,200
1,200
1,100
1,000
941
834
798
725
682
612
562
502
448
384
339
292
242
213
183
179
165
161
233
206
178
276
322
302
305
291
308
334
386
466
614
753
1,100
1,124
1,101
1,216
1,223
1,277
1,380
2,671
2,606
2,464
2,321
2,154
1,983
1,832
1,666
1,485
1,388
1,240
1,134
1,013
982
0
1,153
1,259
1,494
1,564
1,467
1,309
1,246
1,188
1,056
953
841
739
642
5,724
5,665
6,089
6,573
7,673
7,302
6,966
7,240
7,129
6,923
3,875
3,638
3,493
3,967
4,071
4,207
4,673
5,207
5,906
31,628
31,778
32,809
41,583
33,728
30,929
32,122
82,048
84,251
83,425
79,197
85,243
88,408
89,721
81,642
86,137
87,551
127,840
131,914
148,026
148,026131,914127,84087,55186,13781,64289,72188,40885,24379,19783,42584,25182,04832,12230,92933,72841,58332,80931,77831,6285,9065,2074,6734,2074,0713,9673,4933,6383,8756,9237,1297,2406,9667,3027,6736,5736,0895,6655,7246427398419531,0561,1881,2461,3091,4671,5641,4941,2591,15309821,0131,1341,2401,3881,4851,6661,8321,9832,1542,3212,4642,6062,6711,3801,2771,2231,2161,1011,1241,1007536144663863343082913053023222761782062331611651791832132422923393844485025626126827257988349411,0001,1001,2001,200
       Property Plant Equipment 
1,200
1,200
1,100
1,000
941
834
798
725
682
612
562
502
448
384
339
292
242
213
183
179
165
161
233
206
178
276
322
302
305
291
308
334
386
466
614
753
1,100
1,124
1,101
1,216
1,223
1,277
1,380
2,671
2,606
2,464
2,321
2,154
1,983
1,832
1,666
1,485
1,388
1,240
1,134
1,013
982
1,128
1,153
1,259
1,494
1,564
1,467
1,309
1,246
1,188
1,056
953
841
739
642
2,387
2,398
2,892
3,446
4,616
4,315
4,049
4,393
4,351
4,215
3,875
3,638
3,493
3,967
4,071
4,207
4,673
5,207
5,906
31,628
31,778
32,809
32,247
31,919
30,840
31,911
57,738
58,019
58,388
58,532
59,028
59,104
59,502
58,546
57,372
59,048
98,471
103,510
115,097
115,097103,51098,47159,04857,37258,54659,50259,10459,02858,53258,38858,01957,73831,91130,84031,91932,24732,80931,77831,6285,9065,2074,6734,2074,0713,9673,4933,6383,8754,2154,3514,3934,0494,3154,6163,4462,8922,3982,3876427398419531,0561,1881,2461,3091,4671,5641,4941,2591,1531,1289821,0131,1341,2401,3881,4851,6661,8321,9832,1542,3212,4642,6062,6711,3801,2771,2231,2161,1011,1241,1007536144663863343082913053023222761782062331611651791832132422923393844485025626126827257988349411,0001,1001,2001,200
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9,247
1,720
0
0
24,099
26,021
24,826
20,235
25,687
22,803
23,718
21,739
19,962
19,910
20,985
20,231
25,283
25,28320,23120,98519,91019,96221,73923,71822,80325,68720,23524,82626,02124,099001,7209,247000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,337
3,267
3,197
3,127
3,057
2,987
2,917
2,847
2,778
2,708
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7,500
7,344
7,188
7,031
6,875
6,8757,0317,1887,3447,5000000000000000000000000002,7082,7782,8472,9172,9873,0573,1273,1973,2673,33700000000000000000000000000000000000000000000000000000000000000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,337
3,267
3,197
3,127
3,057
2,987
2,917
2,847
2,778
2,708
0
0
0
0
0
0
0
0
0
0
0
0
89
89
89
211
57,919
211
211
430
528
6,501
6,501
1,357
1,303
0
0
0
0
00001,3031,3576,5016,50152843021121157,9192118989890000000000002,7082,7782,8472,9172,9873,0573,1273,1973,2673,33700000000000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
1,300
1,300
2,700
1,800
1,868
2,098
3,044
1,528
1,548
1,804
1,155
1,029
1,254
1,559
1,897
1,002
880
794
1,046
1,011
876
986
917
750
835
641
558
580
643
557
545
558
779
690
801
869
1,309
1,365
1,697
2,539
2,141
2,317
2,293
4,597
4,493
3,167
2,734
2,883
2,541
2,484
2,137
1,992
2,336
2,266
1,947
2,740
3,527
29,900
27,677
30,462
25,230
20,710
60,388
51,149
47,347
5,665
4,278
3,842
7,252
5,321
6,109
17,051
12,597
11,938
12,790
10,975
9,408
12,179
13,831
12,327
16,629
23,889
25,084
22,561
23,541
32,037
31,474
31,595
29,988
16,458
38,174
37,284
40,537
42,147
42,438
39,095
42,874
71,348
71,255
70,853
67,363
73,243
67,803
69,999
70,180
80,731
71,118
111,783
113,745
127,705
127,705113,745111,78371,11880,73170,18069,99967,80373,24367,36370,85371,25571,34842,87439,09542,43842,14740,53737,28438,17416,45829,98831,59531,47432,03723,54122,56125,08423,88916,62912,32713,83112,1799,40810,97512,79011,93812,59717,0516,1095,3217,2523,8424,2785,66547,34751,14960,38820,71025,23030,46227,67729,9003,5272,7401,9472,2662,3361,9922,1372,4842,5412,8832,7343,1674,4934,5972,2932,3172,1412,5391,6971,3651,3098698016907795585455576435805586418357509179868761,0111,0467948801,0021,8971,5591,2541,0291,1551,8041,5481,5283,0442,0981,8681,8002,7001,3001,300
   > Total Current Liabilities 
1,200
1,200
2,700
1,800
1,820
2,068
3,032
1,528
1,548
1,804
1,155
1,029
1,254
1,559
1,897
1,002
880
794
1,046
1,011
876
986
917
750
835
641
558
580
643
557
545
558
779
690
801
869
1,309
1,365
1,697
2,539
2,141
2,317
2,293
3,500
3,504
2,156
1,836
2,100
1,874
1,936
1,710
1,687
2,087
2,072
1,810
2,661
3,487
29,900
27,634
30,419
25,181
20,670
22,347
11,990
6,980
5,659
4,276
3,842
7,252
5,321
6,109
17,051
12,482
11,829
12,624
10,818
9,261
12,108
13,769
11,455
15,360
12,852
14,752
12,943
14,528
13,090
13,878
15,220
14,992
14,792
12,941
12,543
15,112
19,795
20,750
18,121
21,313
22,483
23,230
23,863
18,828
26,052
21,731
25,014
27,004
37,463
28,753
35,611
35,946
45,749
45,74935,94635,61128,75337,46327,00425,01421,73126,05218,82823,86323,23022,48321,31318,12120,75019,79515,11212,54312,94114,79214,99215,22013,87813,09014,52812,94314,75212,85215,36011,45513,76912,1089,26110,81812,62411,82912,48217,0516,1095,3217,2523,8424,2765,6596,98011,99022,34720,67025,18130,41927,63429,9003,4872,6611,8102,0722,0871,6871,7101,9361,8742,1001,8362,1563,5043,5002,2932,3172,1412,5391,6971,3651,3098698016907795585455576435805586418357509179868761,0111,0467948801,0021,8971,5591,2541,0291,1551,8041,5481,5283,0322,0681,8201,8002,7001,2001,200
       Short-term Debt 
200
200
100
100
99
71
72
65
48
30
12
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
439
490
431
438
446
454
463
471
479
418
354
291
226
240
0
159
103
51
40
40
40
40
34
27
19
10
6
2
2,500
38
109
0
0
0
71
0
2,304
5,566
779
1,446
2,112
2,557
350
1,597
2,848
4,097
0
2,385
2,558
2,836
5,461
5,535
5,611
6,143
4,394
4,439
4,652
2,321
2,950
3,188
3,197
4,943
4,302
4,497
7,218
7,267
6,187
6,1877,2677,2184,4974,3024,9433,1973,1882,9502,3214,6524,4394,3946,1435,6115,5355,4612,8362,5582,38504,0972,8481,5973502,5572,1121,4467795,5662,304071000109382,5002610192734404040405110315902402262913544184794714634544464384314904390000000000000000000000000000000012304865727199100100200200
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
109
0
0
0
71
0
0
0
779
1,446
10,163
2,557
350
1,597
2,848
4,097
0
2,385
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000002,38504,0972,8481,5973502,55710,1631,446779000710001090000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
800
1,000
2,400
1,500
1,606
1,899
2,803
1,313
1,350
1,629
964
836
1,057
1,135
1,196
837
793
685
920
856
736
764
741
589
668
485
391
406
463
367
380
382
601
500
614
533
872
730
638
356
912
920
1,012
532
1,823
916
981
907
950
1,085
884
248
1,335
1,366
1,161
973
2,739
2,083
2,308
3,152
3,462
2,239
4,782
4,729
3,986
2,843
3,873
3,792
3,217
2,355
2,881
5,414
3,390
5,824
6,726
6,120
4,995
7,588
6,293
5,305
5,467
6,534
6,335
6,272
5,972
5,552
5,768
5,011
4,580
7,108
6,201
5,250
5,281
6,345
6,400
4,535
6,475
6,755
8,826
8,134
5,575
9,016
7,750
9,684
8,113
16,930
11,125
14,401
15,051
22,347
22,34715,05114,40111,12516,9308,1139,6847,7509,0165,5758,1348,8266,7556,4754,5356,4006,3455,2815,2506,2017,1084,5805,0115,7685,5525,9726,2726,3356,5345,4675,3056,2937,5884,9956,1206,7265,8243,3905,4142,8812,3553,2173,7923,8732,8433,9864,7294,7822,2393,4623,1522,3082,0832,7399731,1611,3661,3352488841,0859509079819161,8235321,0129209123566387308725336145006013823803674634063914856685897417647368569206857938371,1961,1351,0578369641,6291,3501,3132,8031,8991,6061,5002,4001,000800
       Other Current Liabilities 
200
200
200
200
115
98
157
150
150
145
179
193
197
424
701
165
87
109
126
155
140
222
176
161
167
156
167
174
180
190
165
176
178
190
187
336
437
635
1,059
2,183
1,229
1,397
1,281
2,529
1,191
809
417
747
470
388
1,239
1,208
1,669
1,718
1,519
2,435
3,247
27,567
27,475
30,316
25,130
16,625
22,307
11,950
6,940
1,995
4,249
3,823
7,242
2,019
6,107
2,974
4,367
6,005
5,898
4,698
4,266
4,520
7,476
494
697
1,016
941
424
1,485
1,195
2,080
1,747
189
7,684
176
34
35
41
41
7,975
8,695
41
9,965
11,077
10,932
41
10,793
12,133
13,948
16,231
13,131
21
13,628
17,215
17,21513,6282113,13116,23113,94812,13310,7934110,93211,0779,965418,6957,975414135341767,6841891,7472,0801,1951,4854249411,0166974947,4764,5204,2664,6985,8986,0054,3672,9746,1072,0197,2423,8234,2491,9956,94011,95022,30716,62525,13030,31627,47527,5673,2472,4351,5191,7181,6691,2081,2393884707474178091,1912,5291,2811,3971,2292,1831,0596354373361871901781761651901801741671561671611762221401551261098716570142419719317914515015015798115200200200200
   > Long-term Liabilities 
100
100
100
100
48
30
12
1,378
1,398
1,659
976
836
1,057
1,135
1,196
837
793
685
920
856
736
764
741
589
668
485
391
406
463
367
380
382
601
500
614
533
872
730
638
356
912
920
1,012
1,097
989
1,011
898
783
667
548
427
305
249
194
137
79
40
0
43
43
49
40
38,041
39,159
40,367
6
2
19
10
2,361
2
7,914
115
109
166
157
147
71
62
872
1,269
11,037
10,332
9,618
9,013
18,947
17,596
16,375
14,996
1,666
25,233
24,741
25,425
22,352
21,688
20,974
21,561
48,865
48,025
46,990
48,535
47,191
46,072
44,985
43,176
43,268
42,365
76,172
77,799
81,956
81,95677,79976,17242,36543,26843,17644,98546,07247,19148,53546,99048,02548,86521,56120,97421,68822,35225,42524,74125,2331,66614,99616,37517,59618,9479,0139,61810,33211,0371,26987262711471571661091157,91422,36110192640,36739,15938,04140494343040791371942493054275486677838981,0119891,0971,0129209123566387308725336145006013823803674634063914856685897417647368569206857938371,1961,1351,0578369761,6591,3981,378123048100100100100
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
43
49
40
29
19
9
6
2
0
0
0
0
0
115
0
100
91
81
0
62
52
42
32
8,679
8,040
7,400
0
15,649
14,416
13,183
0
133
134
114
110
91
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000091110114134133013,18314,41615,64907,4008,0408,6793242526208191100011500000269192940494300000000000000000000000000000000000000000000000000000000000
       Warrants
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
39,140
80,716
83,226
85,752
85,752
0
0
0
0
0
0
0
0
0
0
0
0
190
0
190
190
190
0
397
302
302
104
104
104
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000001041041043023023970190190190019000000000000085,75285,75283,22680,71639,140000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
66
66
66
0
0
820
1,227
1,687
1,632
1,567
1,613
2,059
1,947
1,959
1,813
1,666
0
134
0
0
0
0
0
0
57
62
0
44
0
0
0
0
0
0
0
0
00000000440625700000013401,6661,8131,9591,9472,0591,6131,5671,6321,6871,2278200066666600000000000000000000000000000000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
820
1,227
0
1,632
1,567
1,613
0
1,947
1,959
1,813
0
133
134
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000013413301,8131,9591,94701,6131,5671,63201,2278200000000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
7,600
4,800
20,200
16,600
13,006
18,814
13,599
10,846
12,195
9,936
7,783
8,511
5,000
2,874
7,862
12,435
11,626
10,492
8,784
10,894
15,850
13,824
12,758
10,803
9,379
8,457
6,734
11,575
14,315
11,945
11,626
17,608
16,292
23,849
36,204
33,028
30,017
26,611
22,384
42,342
39,012
35,923
32,276
28,251
24,858
32,728
28,228
23,334
19,789
17,116
19,818
17,284
17,830
14,358
22,622
17,791
12,443
0
-1,446
-10,158
-11,158
-12,971
-21,724
-20,710
-24,639
9,513
6,304
1,841
4,950
3,894
3,769
2,785
37,784
35,641
31,702
30,244
26,410
22,130
19,226
17,107
11,393
24,709
15,504
13,973
16,737
22,540
20,935
90,598
94,475
102,231
103,055
88,542
96,990
111,091
110,452
107,596
114,630
134,260
140,209
151,092
156,780
170,462
172,485
174,816
177,837
192,272
193,978
198,928
204,380
225,952
225,952204,380198,928193,978192,272177,837174,816172,485170,462156,780151,092140,209134,260114,630107,596110,452111,09196,99088,542103,055102,23194,47590,59820,93522,54016,73713,97315,50424,70911,39317,10719,22622,13026,41030,24431,70235,64137,7842,7853,7693,8944,9501,8416,3049,513-24,639-20,710-21,724-12,971-11,158-10,158-1,446012,44317,79122,62214,35817,83017,28419,81817,11619,78923,33428,22832,72824,85828,25132,27635,92339,01242,34222,38426,61130,01733,02836,20423,84916,29217,60811,62611,94514,31511,5756,7348,4579,37910,80312,75813,82415,85010,8948,78410,49211,62612,4357,8622,8745,0008,5117,7839,93612,19510,84613,59918,81413,00616,60020,2004,8007,600
   Common Stock
0
0
0
0
57,989
57,992
58,243
59,474
59,812
70,677
72,166
72,257
72,281
73,639
86,446
92,367
92,954
92,726
92,734
96,752
103,593
103,593
104,601
104,600
105,628
106,993
107,372
114,951
120,529
120,562
122,743
131,472
132,805
142,815
158,519
158,703
159,180
159,916
160,238
184,492
185,219
186,355
187,191
187,995
189,652
202,694
203,242
203,211
203,579
205,009
211,683
213,107
173,971,085
210,736
28,255,889
217,873
218,358
225,102
225,722
226,967
227,901
228,877
229,868
239,448
242,771
243,215
245,550
245,976
251,358
253,270
259,140
262,789
304,780
305,008
305,931
306,625
307,207
307,766
308,512
309,437
310,208
329,721
368,683
369,540
377,711
383,020
389,074
463,483
468,447
471,180
474,806
480,050
485,141
489,749
493,774
499,103
502,587
510,061
519,360
534,005
544,624
553,902
563,475
575,011
584,900
593,245
602,104
612,059
621,013
629,229
629,229621,013612,059602,104593,245584,900575,011563,475553,902544,624534,005519,360510,061502,587499,103493,774489,749485,141480,050474,806471,180468,447463,483389,074383,020377,711369,540368,683329,721310,208309,437308,512307,766307,207306,625305,931305,008304,780262,789259,140253,270251,358245,976245,550243,215242,771239,448229,868228,877227,901226,967225,722225,102218,358217,87328,255,889210,736173,971,085213,107211,683205,009203,579203,211203,242202,694189,652187,995187,191186,355185,219184,492160,238159,916159,180158,703158,519142,815132,805131,472122,743120,562120,529114,951107,372106,993105,628104,600104,601103,593103,59396,75292,73492,72692,95492,36786,44673,63972,28172,25772,16670,67759,81259,47458,24357,99257,9890000
   Retained Earnings Total Equity
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-237,125
-239,059
-241,848
-251,592
-260,158
-267,410
-275,315
-282,122
-287,011
-284,797
-287,765
-293,760
-298,398
-305,315
-307,685
-312,547
-314,699
-319,115
324,025
-327,675
-330,719
-337,394
-343,591
-353,369
-355,757
-361,164
-360,877
-368,536
-373,187
-374,256
-369,000
-371,858
-391,650
-388,180
-378,679
-383,384
-391,653
-388,035
-375,815
-379,104
-382,890
-387,821
-383,286
-390,377
-399,340
-405,917
-399,995
-407,490
-412,510
0
0
00-412,510-407,490-399,995-405,917-399,340-390,377-383,286-387,821-382,890-379,104-375,815-388,035-391,653-383,384-378,679-388,180-391,650-371,858-369,000-374,256-373,187-368,536-360,877-361,164-355,757-353,369-343,591-337,394-330,719-327,675324,025-319,115-314,699-312,547-307,685-305,315-298,398-293,760-287,765-284,797-287,011-282,122-275,315-267,410-260,158-251,592-241,848-239,059-237,12500000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
-1,300
-1,400
-1,600
-1,700
-45
286
326
339
323
335
-2,500
-2,480
-2,700
-2,700
-2,770
-2,819
10
20
19
-2,862
8
2
-2,862
-2,932
-2,932
-2,932
-2,932
-3,040
-3,040
-3,040
-3,040
-3,165
-3,165
-3,165
-3,165
-2,192
-2,192
-2,192
-2,192
-2,503
-2,503
-2,503
-2,503
-1,940
-1,940
-1,940
-1,940
-2,644
-2,644
-2,644
0
-3,115
-3,115
0
0
-3,652
-3,652
0
0
0
0
-4,135
-267,880
-240,898
-245,439
-3,598
-3,598
0
-38,389
-4,087
-38,389
5
-70
-71
-71
-71
-71
-5,638
-5,918
-6,326
-6,726
-7,093
-7,502
-7,877
-8,279
-6,621
-7,048
-6,892
-18
-39
3
38
29
21
62
146
78
14
-47
-23
-23
-154
-613
-855
-1,146
-978
-636
-621
-463
-100
-100-463-621-636-978-1,146-855-613-154-23-23-471478146622129383-39-18-6,892-7,048-6,621-8,279-7,877-7,502-7,093-6,726-6,326-5,918-5,638-71-71-71-71-705-38,389-4,087-38,3890-3,598-3,598-245,439-240,898-267,880-4,1350000-3,652-3,65200-3,115-3,1150-2,644-2,644-2,644-1,940-1,940-1,940-1,940-2,503-2,503-2,503-2,503-2,192-2,192-2,192-2,192-3,165-3,165-3,165-3,165-3,040-3,040-3,040-3,040-2,932-2,932-2,932-2,932-2,86228-2,862192010-2,819-2,770-2,700-2,700-2,480-2,500335323339326286-45-1,700-1,600-1,400-1,300
   Capital Surplus 00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock00000000000000000000000000000-3,150-3,150-3,150-3,15000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
1,500
1,700
59,500
59,600
1,855
12,116
12,356
12,569
17,262
6,477
2,500
2,480
2,700
2,700
2,770
2,819
2,879
2,889
19
2,862
2,870
2,864
2,862
2,932
108,560
2,932
2,932
3,040
3,040
3,040
3,040
3,165
3,165
3,165
3,165
2,192
2,192
2,192
2,192
186,995
187,722
188,858
189,694
189,935
191,592
204,634
205,182
205,855
206,223
207,653
211,683
216,222
-173,753,631
7,821
-28,024,830
234,995
13,470
0
225,722
226,967
0
228,877
229,868
239,448
242,771
3,598
42,876
42,876
38,389
4,087
38,389
38,389
38,389
38,389
38,389
38,389
38,389
2,488
2,768
3,176
3,766
7,283
7,692
8,067
8,469
7,018
7,445
7,194
302
104
104
104
29
21
62
146
78
14
12,122
12,840
-23
177,933
562,862
574,156
583,754
592,267
-636
-621
0
225,952
225,9520-621-636592,267583,754574,156562,862177,933-2312,84012,12214781466221291041041043027,1947,4457,0188,4698,0677,6927,2833,7663,1762,7682,48838,38938,38938,38938,38938,38938,38938,3894,08738,38942,87642,8763,598242,771239,448229,868228,8770226,967225,722013,470234,995-28,024,8307,821-173,753,631216,222211,683207,653206,223205,855205,182204,634191,592189,935189,694188,858187,722186,9952,1922,1922,1922,1923,1653,1653,1653,1653,0403,0403,0403,0402,9322,932108,5602,9322,8622,8642,8702,862192,8892,8792,8192,7702,7002,7002,4802,5006,47717,26212,56912,35612,1161,85559,60059,5001,7001,500



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue197,516
Cost of Revenue-61,940
Gross Profit135,576135,576
 
Operating Income (+$)
Gross Profit135,576
Operating Expense-142,040
Operating Income-6,464-6,464
 
Operating Expense (+$)
Research Development21,042
Selling General Administrative117,042
Selling And Marketing Expenses0
Operating Expense142,040138,084
 
Net Interest Income (+$)
Interest Income3,959
Interest Expense-600
Other Finance Cost-67
Net Interest Income3,292
 
Pretax Income (+$)
Operating Income-6,464
Net Interest Income3,292
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-2,368-10,560
EBIT - interestExpense = -7,064
-2,368
-2,582
Interest Expense600
Earnings Before Interest and Taxes (EBIT)-6,464-1,768
Earnings Before Interest and Taxes (EBITDA)-1,832
 
After tax Income (+$)
Income Before Tax-2,368
Tax Provision-414
Net Income From Continuing Ops-10,253-2,782
Net Income-3,182
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses203,980
Total Other Income/Expenses Net4,096-3,292
 

Technical Analysis of Vericel Corp Ord
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Vericel Corp Ord. The general trend of Vericel Corp Ord is BULLISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Vericel Corp Ord's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (71.4%) Bearish trend (-71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Vericel Corp Ord.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 53.05.

The bearish price targets are: 43.87 > 43.48 > 41.58.

Tweet this
Vericel Corp Ord Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Vericel Corp Ord. The current mas is .

The long score for the Moving Averages is 12/14.
The longshort score for the Moving Averages is 10/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Vericel Corp Ord Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Vericel Corp Ord. The current macd is 0.33148551.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Vericel Corp Ord price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Vericel Corp Ord. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Vericel Corp Ord price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Vericel Corp Ord Daily Moving Average Convergence/Divergence (MACD) ChartVericel Corp Ord Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Vericel Corp Ord. The current adx is 21.71.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Vericel Corp Ord shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Vericel Corp Ord Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Vericel Corp Ord. The current sar is 52.07.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Vericel Corp Ord Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Vericel Corp Ord. The current rsi is 40.88. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending down: The RSI is trending down. -1
Vericel Corp Ord Daily Relative Strength Index (RSI) ChartVericel Corp Ord Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Vericel Corp Ord. The current phase is Oversold in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Vericel Corp Ord price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Vericel Corp Ord Daily Stochastic Oscillator ChartVericel Corp Ord Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Vericel Corp Ord. The current cci is -96.34955106.

Vericel Corp Ord Daily Commodity Channel Index (CCI) ChartVericel Corp Ord Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Vericel Corp Ord. The current cmo is -34.26726809.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Vericel Corp Ord Daily Chande Momentum Oscillator (CMO) ChartVericel Corp Ord Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Vericel Corp Ord. The current willr is -96.03960396.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Vericel Corp Ord Daily Williams %R ChartVericel Corp Ord Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Vericel Corp Ord.

Vericel Corp Ord Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Vericel Corp Ord. The current atr is 1.64873488.

Vericel Corp Ord Daily Average True Range (ATR) ChartVericel Corp Ord Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Vericel Corp Ord. The current obv is 7,801,694.

Vericel Corp Ord Daily On-Balance Volume (OBV) ChartVericel Corp Ord Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Vericel Corp Ord. The current mfi is 26.73.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Vericel Corp Ord Daily Money Flow Index (MFI) ChartVericel Corp Ord Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Vericel Corp Ord.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-27STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-30STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-01STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-18CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-20WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-28STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-29ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-30RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-02MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-08CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-13RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-15BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-02-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-26SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-01WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-07STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-26BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-27ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-01STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-02RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-03MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-16WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside

6.3. Candlestick Patterns

Vericel Corp Ord Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Vericel Corp Ord based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5040.880
Ma 20Greater thanMa 5049.351
Ma 50Greater thanMa 10047.426
Ma 100Greater thanMa 20042.353
OpenGreater thanClose47.940
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Vericel Corp Ord with someone you think should read this too:
  • Are you bullish or bearish on Vericel Corp Ord? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Vericel Corp Ord? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Vericel Corp Ord

I send you an email if I find something interesting about Vericel Corp Ord.


Comments

How you think about this?

Leave a comment

Stay informed about Vericel Corp Ord.

Receive notifications about Vericel Corp Ord in your mailbox!